NCT02615197View on ClinicalTrials.gov

Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Post-traumatic Stress DisorderSuicideSelf-injurious Behavior
Interventions
BEHAVIORAL

Dialectical Behavior Therapy

Includes all components of standard DBT (individual therapy, group skills training, phone coaching, and therapist consultation team).

BEHAVIORAL

Dialectical Behavior Therapy Prolonged Exposure protocol

Includes an adapted version of Prolonged Exposure therapy for PTSD.

Trial Locations (1)

98105

Behavioral Research and Therapy Clinics, University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Washington

OTHER

NCT02615197 - Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients | Biotech Hunter | Biotech Hunter